Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156013
Status:
COMPLETED
Last Update Posted:
2017-11-29
First Post:
2005-09-08
Brief Title:
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma NHL
Sponsor:
Oncology Specialists SC
Organization:
Oncology Specialists SC
Organization Data
Organization:
Oncology Specialists SC
Class:
OTHER
Study ID:
1066306 0408
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncology Specialists SC
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Sigrun Hallmeyer
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oncology Specialists SC
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genzyme a Sanofi Company | INDUSTRY |